Brief: Mabpharm Announces Acceptance Of NDA Of Cmab007 (Omalizumab) By Nmpa
15/10/2021 13:00
Mabpharm Ltd 2181.HK :
* MABPHARM ANNOUNCES ACCEPTANCE OF NDA OF CMAB007
(OMALIZUMAB) BY
NMPA
Source text for Eikon: ID:
Further company coverage: 2181.HK
Recent news on Mabpharm
See all newsBrief: Mabpharm Says NMPA Approves CMAB807X (Denosumab Injection) NDA
Brief: Mabpharm Says NMPA Approves Cmab807 (Denosumab Injection) NDA
Brief: Mabpharm FY Profit And Total Comprehensive Income Attributable Rmb57.1 Million
Brief: Mabpharm Says Approval From Drug Regulatory Authority Of Pakistan On Registration Of Core Product,CMAB008
Brief: Mabpharm Says Approval From Indonesian National Agency Of Drug And Food Control Of CMAB008